## 3 Results
### General Results
Hoses were evaluated by a lameness examination and US before and 3 months after treatment & \multirow{2}{*}{20 months} & \multirow{2}{*}{Positive} \\ \cline{1-1} \cline{5-5}  & Case series, 9 horses with SDFT, 1 with inferior check ligament injury, and 1 with tendmothey of the deep digital record (DoDFT). To evaluate the effect of an autologous PRP product (autologous command plasma (ACP) on lanneness scores and US changes. & 2.5 mL of PRP obtained by a gravitational method was injected L, only once perforated structure. Hoses were evaluated by a lameness examination and US before and 3 months after treatment & \multirow{2}{*}{20 months} & \multirow{2}{*}{Positive} \\ \cline{1-1} \cline{5-5}  & Case series, 9 horses with SDFT, 1 with inferior check ligament injury, and 1 with tendmothey of the deep digital record (DoDFT). To evaluate the effect of an autologous PRP product (autologous command plasma (ACP) on lanneness scores and US changes. & 2.5 mL of PRP obtained by a gravitational method was injected L, only once perforated structure. Hoses were evaluated by a lameness examination and US before and 3 months after treatment & \multirow{2}{*}{20 months} & \multirow{2}{*}{Positive} \\ \cline{1-1} \cline{5-5}  & Case series, 9 horses with mildly SDFT, 1 with inferior check ligament injury, and 1 with tendmothey of the deep digital record (DoDFT). To evaluate the effect of an ANGPRP product (autologous command plasma (ACP) on lanneness scores and US changes. & 2.5 mL of PRP obtained by a gravitational method was injected L, only once perforated structure \begin{table}
\begin{tabular}{p{14.2 pt} p{142.3 pt} p{142.3 pt} p{142.3 pt} p{142.3 pt} p{142.3 pt}} \hline \hline
**Study** & **Study Type, Number of Animals, and Objectives** & **Study Design** & **Results and Adverse Effects** & **Length of Follow-Up** & **Outcome** \\ \hline \multirow{4}{*}{[PERSON] et al. [40]} & Case series; 104 horses. The aim was to evaluate the combination of allogenic mesenchymal stem cells (MSCs) and PRP by US and lanes examinations in 68 horses with SLD and 36 with SDFTT. & One IL injection of 2-3 \(\times\) 10\({}^{6}\) & At 24 months, 82.4\% of horses with SDFTT & \multirow{4}{*}{24 months} & \multirow{4}{*}{Positive} \\  & Case series; 9 horses with SDFT. & One only dose of 1 \(\times\) 10\({}^{6}\) & Seven horses resumed their normal competitive activity after 9 months. & \multirow{4}{*}{9 months} & \multirow{4}{*}{Positive} \\  & The aim was to evaluate the combination of allogenic mesenchymal stem cells (MSCs) and PRP by US and lanes examinations in 68 horses with SDFTT. & 2, and 4 months. & Two horses were reinjured. No adverse effects. & \multirow{4}{*}{9 months} & \multirow{4}{*}{Positive} \\  & Case series; 9 horses with SDFT. & One only dose of 2-6 mL of PRP & Seven horses (89.5\%) returned to competition, while two (10.5\%) were repaired. No adverse effects were & \multirow{4}{*}{24 months} & \multirow{4}{*}{Positive} \\  & The aim was to evaluate the effect of allogenic AD-MSCs in combination with autologous PRP by US and performance results. & & & & \\ \hline \multirow{4}{*}{[PERSON] et al. [43]} & Case series; 13 horses, 12 with SLD and 1 with SDFTT. The aim was to evaluate the effect of allogenic the effect of allogenous bone marrow mononuclear cells (BMMNCs) plus PRP by US, tameness examination, and performance results. & All horses showed an US improvement. Eleven horses (84.6\%) returned to competition. Faster recovery was observed in horses treated with PRP with more than 750 \(\times\) 10\({}^{9}\)/ul. platelets (2.8 \(\pm\) 0.4 months) with respect to horses who received less concentrated PRP (7.9\%. & \multirow{4}{*}{12 months} & \multirow{4}{*}{Positive} \\  & The acronyms are the same as in Table 1. & & & \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Case series in which the effects of various PRP preparations combined with mesenchymal stem cells (MSCs) and bone marrow mononucleated cells (BMMNCs) were evaluated in horses with tendon and ligament injuries.